Does METHYLDOPA Cause Ventricular septal defect? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Ventricular septal defect have been filed in association with METHYLDOPA (Methyldopa). This represents 0.7% of all adverse event reports for METHYLDOPA.
19
Reports of Ventricular septal defect with METHYLDOPA
0.7%
of all METHYLDOPA reports
1
Deaths
1
Hospitalizations
How Dangerous Is Ventricular septal defect From METHYLDOPA?
Of the 19 reports, 1 (5.3%) resulted in death, 1 (5.3%) required hospitalization.
Is Ventricular septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLDOPA. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLDOPA Cause?
Foetal exposure during pregnancy (1,028)
Premature baby (792)
Maternal exposure during pregnancy (623)
Premature delivery (519)
Exposure during pregnancy (502)
Low birth weight baby (350)
Foetal growth restriction (172)
Drug ineffective (162)
Live birth (153)
Off label use (152)
What Other Drugs Cause Ventricular septal defect?
ONDANSETRON (301)
LAMOTRIGINE (238)
PAROXETINE (225)
SERTRALINE (193)
LEVETIRACETAM (172)
FLUOXETINE (171)
CITALOPRAM HYDROBROMIDE (158)
VENLAFAXINE (152)
ASPIRIN (146)
RAMIPRIL (145)
Which METHYLDOPA Alternatives Have Lower Ventricular septal defect Risk?
METHYLDOPA vs METHYLENE BLUE
METHYLDOPA vs METHYLENEDIOXYPYROVALERONE
METHYLDOPA vs METHYLERGONOVINE
METHYLDOPA vs METHYLNALTREXONE
METHYLDOPA vs METHYLPHENIDATE